{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:51:30Z","timestamp":1791010290844,"version":"4.1.0"},"reference-count":145,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T00:00:00Z","timestamp":1449532800000},"content-version":"vor","delay-in-days":5668,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1046\/j.1523-1755.2000.00080.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:35:33Z","timestamp":1047461733000},"page":"2195-2206","source":"Crossref","is-referenced-by-count":178,"title":["Antiproteinase 3- and antimyeloperoxidase-associated vasculitis"],"prefix":"10.1016","volume":"57","author":[{"given":"Casper F.M.","family":"Franssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coen A.","family":"Stegeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees G.M.","family":"Kallenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinold O.B.","family":"Gans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"De Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Hoorntje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem Cohen","family":"Tervaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0010","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.285.6342.606","article-title":"Segmental necrotizing glomerulonephritis with antineutrophil antibody: Possible arbovirus etiology?","volume":"285","author":"Davies","year":"1982","journal-title":"Br Med J"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies to neutrophils and monocytes: A new tool for diagnosis and a marker of disease activity in Wegener's granulomatosis","volume":"2","author":"van der Woude","year":"1985","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0020","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","article-title":"Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis","volume":"318","author":"Falk","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0025","first-page":"558","article-title":"Autoantibodies against myeloid lysosomal enzymes: A novel class of autoantibodies associated with vasculitic syndromes","volume":"34","author":"Goldschmeding","year":"1988","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0030","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1172\/JCI114335","article-title":"Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils","volume":"84","author":"Goldschmeding","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0035","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood.V75.11.2263.2263","article-title":"Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3","volume":"78","author":"Jennette","year":"1990","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0091-6749(05)80067-3","article-title":"A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease","volume":"86","author":"Saxon","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0045","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/0016-5085(91)70028-V","article-title":"Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis","volume":"100","author":"Duerr","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0050","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/gut.33.5.668","article-title":"Anti-neutrophil cytoplasmic antibodies in inflammatory bowel diseases: Prevalence and diagnostic role","volume":"33","author":"Cambridge","year":"1992","journal-title":"Gut"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.1840170310","article-title":"Prevalence and characterization of anti-neutrophil cytoplasmic antibodies in autoimmune liver diseases","volume":"17","author":"Mulder","year":"1993","journal-title":"Hepatology"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0060","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/art.1780360805","article-title":"Antineutrophil cytoplasm antibodies in rheumatoid arthritis: Characterization and clinical correlations","volume":"36","author":"Mulder","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2249.1992.tb06408.x","article-title":"Anti-neutrophil cytoplasmic antibodies in patients with symptomatic HIV infection","volume":"87","author":"Klaassen","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0070","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0140-6736(91)92694-W","article-title":"Antineutrophil cytoplasmic antibodies, cystic fibrosis and infection","volume":"337","author":"Efthiniou","year":"1991","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0075","first-page":"449","article-title":"Antineutrophil-cytoplasmic-autoantibodies in poststreptococcal nephritis","author":"Mezzano","year":"1993"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0080","first-page":"15","article-title":"The presence of cytoplasmic antineutrophil cytoplasmic antibodies (C-ANCA) in the course of subacute bacterial endocarditis with glomerular involvement, coincidence or association?","volume":"49","author":"Subra","year":"1998","journal-title":"Clin Nephrol"},{"issue":"Suppl 1","key":"10.1046\/j.1523-1755.2000.00080.x_bb0085","first-page":"12","article-title":"ANCA in diseases other than systemic vasculitis","volume":"93","author":"Peter","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0090","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0002-9343(92)90202-M","article-title":"Antineutrophil cytoplasmic antibodies: A still-growing class of autoantibodies in inflammatory disorders","volume":"93","author":"Kallenberg","year":"1992","journal-title":"Am J Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.1993.tb03345.x","article-title":"ANCA and associated diseases: Immunodiagnostic and pathogenetic aspects","volume":"91","author":"Gross","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/gut.34.1.56","article-title":"Antilactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis and Crohn's disease","volume":"34","author":"Peen","year":"1993","journal-title":"Gut"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2249.1992.tb05835.x","article-title":"Antineutrophil cytoplasmic antibodies (ANCA) directed against vathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis","volume":"90","author":"Halbwachs-Mecarelli","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0110","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0140-6736(93)92686-N","article-title":"Is p-ANCA in ulcerative colitis directed against \u03b2-glucuronidase?","volume":"341","author":"Kaneko","year":"1993","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-4757-9182-2_40","article-title":"Autoantibodies directed against lysosyme: A new target antigen for anti-neutrophil cytoplasmic autoantibodies","volume":"336","author":"Schmitt","year":"1993","journal-title":"Adv Exp Med Biol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides: Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0125","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/blood.V74.6.1888.1888","article-title":"Wegener's granulomatosis autoantigen is a novel serine proteinase","volume":"74","author":"Niles","year":"1989","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1084\/jem.171.1.357","article-title":"Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme","volume":"171","author":"L\u00fcdemann","year":"1990","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0135","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1172\/JCI114518","article-title":"Azurocidin and a homologeous serine protease from neutrophils: Differential antimicrobial and proteolytic properties","volume":"85","author":"Campanelli","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-5793(92)80340-M","article-title":"Substrate and inhibitor studies on proteinase 3","volume":"297","author":"Kam","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0145","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1073\/pnas.86.14.5610","article-title":"Antibiotic proteins of human polymorphonuclear leukocytes","volume":"86","author":"Gabay","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0150","first-page":"1","article-title":"ANCA antigens: Proteinase 3,","author":"Wieslander","year":"1994"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0155","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1172\/JCI113816","article-title":"Proteinase 3: A distinct human polmorphonuclear leukocyte proteinase that induces emphysema in hamsters","volume":"82","author":"Kao","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0160","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/art.1780370116","article-title":"Elevations of neutrophil proteinase 3 in serum of patients with Wegener's granulomatosis and polyarteritis nodosa","volume":"37","author":"Henshaw","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0165","first-page":"1","article-title":"ANCA antigens: Myeloperoxidase,","author":"Wieslander","year":"1994"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0170","first-page":"295","article-title":"Immunocytochemical localization of myeloperoxidase, lactoferrin, lysosyme and neutral proteases in human monocytes and neutrophil granulocytes","volume":"24","author":"Pryzwansky","year":"1978","journal-title":"J Reticuloendothel Soc"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0175","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0021-9258(17)33749-3","article-title":"Studies on the chlorinating activity of myeloperoxidase","volume":"251","author":"Harrison","year":"1976","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM198902093200606","article-title":"Tissue destruction by neutrophils","volume":"320","author":"Weiss","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0272-6386(95)90147-7","article-title":"Significance of myeloperoxidase in rapidly progressive glomerulonephritis","volume":"26","author":"Saeki","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2249.1997.d01-992.x","article-title":"Binding and inhibition of myelo-peroxidase (MPO): A major function of ceruloplasmin?","volume":"108","author":"Segelmark","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0195","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1046\/j.1523-1755.1999.055003917.x","article-title":"The inhibition of myeloperoxidase by ceruloplasmin can be reversed by antimyeloperoxidase antibodies","volume":"55","author":"Griffin","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0200","first-page":"249","article-title":"Characterization of monoclonal antibodies to proteinase-3 and application in the study of epitopes for classical antineutrophil cytoplasm antibodies","volume":"3","author":"Sommarin","year":"1995","journal-title":"Exp Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0205","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.4049\/jimmunol.152.9.4722","article-title":"Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis","volume":"152","author":"Williams","year":"1994","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0210","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4049\/jimmunol.149.4.1409","article-title":"Antineutrophil cytoplasmic autoantibodies in Wegener's granulomatosis recognize conformational epitope(s) on proteinase 3","volume":"149","author":"Bini","year":"1992","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0215","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2249.1995.tb06644.x","article-title":"Epitope mapping of antiproteinase 3 and antimyeloperoxidase antibodies","volume":"102","author":"Chang","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0220","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2249.1997.d01-895.x","article-title":"Antinative and recombinant monoclonals and human autoantibodies","volume":"107","author":"Audrain","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0225","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2249.1997.tb08327.x","article-title":"Studies on epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitis","volume":"110","author":"Short","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0230","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1023\/A:1023251001261","article-title":"A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants","volume":"18","author":"Tomizawa","year":"1998","journal-title":"J Clin Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0235","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2249.1992.tb06944.x","article-title":"Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase","volume":"89","author":"Falk","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0240","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00918805","article-title":"Autoantibodies to native myeloperoxidase in patients with pulmonary hemorrhage and acute renal failure","volume":"11","author":"Roberts","year":"1991","journal-title":"J Clin Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0245","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4757-9182-2_13","article-title":"Antineutrophil cytoplasmic autoantibodies (ANCA) recognizing a recombinant myeloperoxidase subunit","volume":"336","author":"Pedrollo","year":"1993","journal-title":"Adv Exp Med Biol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0250","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2249.1992.tb05860.x","article-title":"Interference of Wegener's granulomatosis autoantibodies with neutrophil proteinase 3 activity","volume":"90","author":"Wiel","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0255","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2249.1993.tb08192.x","article-title":"Relevance of classic antineutrophil cytoplasmic autoantibodies (c-ANCA) mediated inhibition of proteinase 3-\u03b11-antitrypsin complexation to disease activity in Wegener's granulomatosis","volume":"93","author":"Dolman","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0260","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/ki.1995.216","article-title":"Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis","volume":"47","author":"Daouk","year":"1995","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0265","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.1991.tb05647.x","article-title":"Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies in patients with Wegener's granulomatosis and clinically related conditions","volume":"83","author":"Brouwer","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1994.239","article-title":"Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential","volume":"46","author":"Kallenberg","year":"1994","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0275","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(97)80118-3","article-title":"Primary systemic vasculitis","volume":"349","author":"Savage","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0280","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-1759(97)00154-3","article-title":"Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies","volume":"208","author":"Wang","year":"1997","journal-title":"J Immunol Methods"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0285","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/ajcp\/111.3.363","article-title":"Diagnostic usefulness of antineutrophil cytoplasmic autoantibody serology","volume":"111","author":"Lim","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(96)00111-1","article-title":"Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA): A report on the second phase of an international cooperative study on the standardization of ANCA assays","volume":"196","author":"Hagen","year":"1996","journal-title":"J Immunol Methods"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0295","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","article-title":"Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA): A report on the second phase of an international cooperative study on the standardization of ANCA assays","volume":"53","author":"Hagen","year":"1998","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0300","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/archinte.1989.00390110055012","article-title":"Association between active Wegener's granulomatosis and cytoplasmic antibodies","volume":"149","author":"Cohen Tervaert","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0305","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-111-1-28","article-title":"Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener's granulomatosis","volume":"111","author":"N\u00f6lle","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0310","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1681\/ASN.V271227","article-title":"Antineutrophil cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis","volume":"2","author":"Weber","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0315","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(95)91555-9","article-title":"A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis","volume":"346","author":"Rao","year":"1995","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0320","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.1780330829","article-title":"Associations of autoantibodies to myeloperoxidase with different forms of vasculitis","volume":"33","author":"Cohen Tervaert","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0325","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/ndt\/6.10.689","article-title":"Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis","volume":"6","author":"Gaskin","year":"1991","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0330","first-page":"125","article-title":"Clinical spectrum associated with ANCA of defined specificities in 98 selected patients","volume":"39","author":"Geffriaud-Ricouard","year":"1993","journal-title":"Clin Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0335","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ki.1990.48","article-title":"Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis","volume":"37","author":"Cohen Tervaert","year":"1990","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0340","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2249.1994.tb06578.x","article-title":"Invasive amoebiasis is associated with the development of antineutrophil cytoplasmic antibody","volume":"97","author":"Pufifin","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0345","first-page":"313","article-title":"Antineutrophil cytoplasmic antibodies: New tools in the diagnosis and follow-up of necrotizing glomerulonephritis","author":"Kallenberg","year":"1992"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0350","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2796.1998.00357.x","article-title":"Disease spectrum of patients with anti-neutrophil cytoplasmic autoantibodies: Distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies","volume":"244","author":"Franssen","year":"1998","journal-title":"J Intern Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0355","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/thx.46.1.70","article-title":"Anti-myeloperoxidase antibodies in the Churg-Strauss syndrome","volume":"46","author":"Cohen Tervaert","year":"1991","journal-title":"Thorax"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0360","first-page":"1345","article-title":"Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome","volume":"20","author":"Guillevin","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0365","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-9343(91)90074-8","article-title":"Detection of autoantibodies against myeloid lysosomal enzymes: A useful adjunct to classification of patients with biopsy-proven necrotizing arthritis","volume":"91","author":"Cohen Tervaert","year":"1991","journal-title":"Am J Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0370","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ki.1990.72","article-title":"Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis","volume":"37","author":"Jayne","year":"1990","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0375","first-page":"107","article-title":"Prognostic implication of antineutrophil cytoplasmic antibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease","volume":"36","author":"Bosch","year":"1991","journal-title":"Clin Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0380","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2249.1990.tb05342.x","article-title":"Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus","volume":"81","author":"N\u00e4ssberger","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0385","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2796.1991.tb00342.x","article-title":"Antibodies to neutrophil granulocyte myeloperoxidase and elastase: Autoimmune responses in glomerulonephritis due to hydralazine treatment","volume":"229","author":"N\u00e4ssberger","year":"1991","journal-title":"J Intern Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0390","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0896-8411(91)90163-7","article-title":"Anti-myeloperoxidase antibodies: Immunological characteristics and clinical associations","volume":"4","author":"Gueirard","year":"1991","journal-title":"J Autoimmun"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0395","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(93)91761-A","article-title":"Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy","volume":"342","author":"Dolman","year":"1994","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0400","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2249.1991.tb08154.x","article-title":"Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitis and infections","volume":"84","author":"Gallichio","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0405","first-page":"22","article-title":"Clinical significance of the ANCA test for diagnosis of systemic necrotizing vasculitis","author":"Andrassy","year":"1991"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0410","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/ndt\/13.4.985","article-title":"Antineutrophil cytoplasmic autoantibodies in atheroembolic disease","volume":"13","author":"Kaplan-Pavlovcic","year":"1998","journal-title":"Nephrol Dial Tranplant"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0415","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-113-9-656","article-title":"Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis","volume":"113","author":"Falk","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0420","first-page":"114","article-title":"Different immunological specificities and disease associations of c-ANCA and p-ANCA","volume":"36","author":"Goldschmeding","year":"1990","journal-title":"Neth J Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0425","first-page":"921","article-title":"Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis","volume":"135","author":"Jennette","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0430","first-page":"31","article-title":"Clinical significance of antibodies to myeloperoxidase in vasculitic syndromes","author":"Sinico","year":"1991"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0435","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0440","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0046-8177(93)90295-R","article-title":"Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis","volume":"24","author":"Fienberg","year":"1993","journal-title":"Hum Pathol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0445","first-page":"145","article-title":"Disease associations with antineutrophil cytoplasmic antibodies","author":"Pusey","year":"1993"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0450","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0272-6386(12)80521-X","article-title":"Antineutrophil cytoplasmic autoantibodies and associated diseases: A review","volume":"6","author":"Jennette","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0455","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener's granulomatosis: An analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0460","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0272-6386(88)80079-9","article-title":"Rapidly progressive glomerulonephritis: Classification, pathogenetic mechanisms, and therapy","volume":"11","author":"Couser","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0465","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ki.1995.23","article-title":"Differences between anti-myeloperoxidase- and anti-proteinase 3 associated renal disease","volume":"47","author":"Franssen","year":"1995","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0470","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000187311","article-title":"Clinical features and outcome in patients with glomerulonephritis and antineutrophil cytoplasmic autoantibodies","volume":"64","author":"Gans","year":"1993","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0475","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ki.1987.67","article-title":"The existence of a protracted course in crescentic glomerulonephritis","volume":"31","author":"Baldwin","year":"1987","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0480","first-page":"285","article-title":"Two distinct types of crescentic glomerulonephritis","volume":"37","author":"Takeda","year":"1992","journal-title":"Clin Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0485","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0899-7071(97)00075-2","article-title":"Wegener's granulomatosis upper respiratory tract and pulmonary radiographic manifestation in 30 cases with pathogenetic consideration","volume":"22","author":"Shin","year":"1998","journal-title":"Clin Imaging"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0490","first-page":"517","article-title":"Antineutrophil cytoplasmic autoantibodies-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage","volume":"118","author":"Bosch","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0495","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1681\/ASN.V7123","article-title":"Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis","volume":"7","author":"Hogan","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0500","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1378\/chest.110.2.357","article-title":"Respiratory failure in ANCA-associated vasculitis","volume":"110","author":"Ter Maaten","year":"1996","journal-title":"Chest"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0505","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of nasal carriage of Staphylococcus aureus and higher relapse rate in Wegener's granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0510","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0140-6736(90)92205-V","article-title":"Prevention of relapses of Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre","volume":"336","author":"Cohen Tervaert","year":"1990","journal-title":"Lancet"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0515","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/art.1780360312","article-title":"Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis","volume":"36","author":"Kerr","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0520","first-page":"219","article-title":"Anti-neutrophil cytoplasmic antibody (c-ANCA and p-ANCA) titers in relation to disease activity in patients with necrotizing vasculitis: A longitudinal study","volume":"37","author":"Peterson","year":"1992","journal-title":"Clin Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0525","first-page":"127","article-title":"ANCA and predicting relapse in systemic vasculitis","volume":"88","author":"Jayne","year":"1995","journal-title":"Q J Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0530","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/ndt\/14.7.1667","article-title":"Relationship between ANCA and disease activity in small-vessel vasculitis patients with anti-MPO ANCA","volume":"14","author":"Ara","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0535","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0002-9343(99)00064-9","article-title":"Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis","volume":"106","author":"Kyndt","year":"1999","journal-title":"Am J Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0540","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1681\/ASN.V9101915","article-title":"Determinants of renal outcome in antimyeloperoxidase associated glomerulonephritis","volume":"9","author":"Franssen","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0545","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ki.1989.312","article-title":"Risk factors in idiopathic renal vasculitis and glomerulonephritis","volume":"36","author":"Wilkowski","year":"1989","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0550","first-page":"139","article-title":"Wegener's granulomatosis with renal involvement: Patient survival and correlations between initial renal function, renal histology, therapy and renal outcome","volume":"35","author":"Andrassy","year":"1991","journal-title":"Clin Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0555","first-page":"779","article-title":"Relapses in patients with a systemic vasculitis","volume":"86","author":"Gordon","year":"1993","journal-title":"Q J Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0560","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1523-1755.1998.00743.x","article-title":"Animal models of anti-neutrophil cytoplasmic autoantibody associated vasculitis","volume":"53","author":"Heeringa","year":"1998","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0565","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1084\/jem.177.4.905","article-title":"Anti-myeloperoxidase associated proliferative glomerulonephritis: An animal model","volume":"177","author":"Brouwer","year":"1993","journal-title":"J Exp Med"},{"issue":"Suppl 1","key":"10.1046\/j.1523-1755.2000.00080.x_bb0570","first-page":"2","article-title":"Neutrophils, vasculitis and ANCA","volume":"112","author":"Kallenberg","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0575","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ki.1994.149","article-title":"Neutrophil activation in vitro and in vivo in Wegener's granulomatosis","volume":"45","author":"Brouwer","year":"1994","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0580","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Antineutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0585","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jlb.50.6.539","article-title":"Antibodies against granule proteins activate neutrophils in vitro","volume":"50","author":"Charles","year":"1991","journal-title":"J Leukoc Biol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0590","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2249.1992.tb07934.x","article-title":"Activation of normal neutrophils by antineutrophil cytoplasm antibodies","volume":"90","author":"Keogan","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0595","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2249.1994.tb06137.x","article-title":"Activation of granulocytes by anti-neutrophil cytoplasm antibodies: A Fc\u03b3RII-dependent process","volume":"98","author":"Mulder","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0600","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ki.1992.52","article-title":"Anti-myeloperoxidase antibodies stimulate neutrophils to damage endothelial cells","volume":"41","author":"Ewert","year":"1992","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0605","first-page":"335","article-title":"Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells","volume":"141","author":"Savage","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0610","first-page":"135","article-title":"Pathogenic potential of antineutrophil cytoplasmic autoantibodies","volume":"70","author":"Jennette","year":"1994","journal-title":"Lab Invest"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0615","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1681\/ASN.V1071506","article-title":"In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis","volume":"10","author":"Franssen","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0620","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2249.1993.tb08215.x","article-title":"Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells","volume":"94","author":"Mayet","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0625","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2249.1996.d01-626.x","article-title":"Antibodies to proteinase 3 mediate expression of vascular cell adhesion molecule-1","volume":"103","author":"Mayet","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0630","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1365-2249.1997.3741271.x","article-title":"Up-regulation of the endothelial cell adhesion molecule-1 (ICAM-1) by autoantibodies in autoimmune vasculitis","volume":"108","author":"Johnsson","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0635","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/art.1780401116","article-title":"Induction of interleukin 1 and subsequent tissue factor expression by anti-proteinase 3 antibodies in human umbilical vein endothelial cells","volume":"40","author":"De Bandt","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0640","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0049-0172(97)80010-8","article-title":"Specificity, pathogenicity, and clinical value of antiendothelial cell antibodies","volume":"27","author":"Belizna","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0645","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/art.1780390507","article-title":"Antiendothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion","volume":"39","author":"Del Papa","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0650","first-page":"433","article-title":"In vitro upregulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis","volume":"17","author":"Muller Kobold","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0655","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0272-6386(96)90030-X","article-title":"Intraglomerular and interstitial leukocyte infiltration, adhesion molecules, and interleukin-1\u03b1 expression in 15 cases of antineutrophil cytoplasmic autoantibody-associated renal vasculitis","volume":"27","author":"Rastaldi","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0660","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780350914","article-title":"Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis","volume":"35","author":"Schmitt","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0665","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2249.1993.tb05918.x","article-title":"Serum markers of T-cell activation in relapses of Wegener's granulomatosis","volume":"91","author":"Stegeman","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0670","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9343(97)00049-1","article-title":"High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis","volume":"102","author":"Wang","year":"1997","journal-title":"Am J Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0675","series-title":"Antiproteinase 3 and Anti-Myeloperoxidase Associated Systemic Vasculitis: Differences in Clinical Presentation and Pathophysiology","first-page":"103","article-title":"Markers of T-cell and monocyte activation in antiproteinase 3 and antimyeloperoxidase associated crescentic glomerulonephritis","author":"Franssen","year":"1998"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0680","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2249.1994.tb05511.x","article-title":"T-cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis","volume":"98","author":"Brouwer","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0685","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2249.1998.00615.x","article-title":"T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA associated systemic vasculitis and persist during disease remission","volume":"112","author":"King","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0690","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2249.1996.d01-629.x","article-title":"T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis","volume":"103","author":"Griffith","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0695","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ki.1993.186","article-title":"Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis","volume":"43","author":"Esnault","year":"1993","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0700","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2249.1995.tb03652.x","article-title":"\u03b11-Antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis","volume":"100","author":"Savige","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0705","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/oxfordjournals.ndt.a027308","article-title":"C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-anti-neutrophil cytoplasmic antibody positivity with the S allele","volume":"11","author":"Griffith","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0710","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ki.1995.360","article-title":"The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis","volume":"48","author":"Segelmark","year":"1995","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0715","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A","article-title":"Antineutrophil cytoplasmic antibodies","volume":"41","author":"Hoffman","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0720","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/pgmj.71.840.605","article-title":"An audit of ANCA in routine clinical practice","volume":"71","author":"Edgar","year":"1995","journal-title":"Postgrad Med"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0725","first-page":"227","article-title":"ANCA defines the clinical disease manifestations of vasculitis: The \u201ccon\u201d side of the issue","volume":"13","author":"Colby","year":"1996","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1046\/j.1523-1755.2000.00080.x_bb0730","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1699-0463.1995.tb01083.x","article-title":"Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis","volume":"103","author":"Gross","year":"1995","journal-title":"APMIS"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815469790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815469790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T21:24:42Z","timestamp":1682112282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815469790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":145,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S0085253815469790"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00080.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}